SPERA PHARMA, Inc.

With passion and exceptional technologies,
experts in CMC research support the creation of outstanding and innovative drugs.

PICK UP

About Us

SPERA PHARMA was established as a spin-out of Takeda Pharmaceutical Company by Chemistry, Manufacturing and Controls (CMC) research experts, who were already responsible for delivering numerous new drugs to high global acclaim.
READ MORE
Services

With passion and exceptional technologies,
experts in CMC research support the creation of outstanding and innovative drugs.
READ MORE
Technology

SPERA PHARMA has inherited and is deepening further the various technologies and know-how that have been cultivated through research and development and practical use in Takeda Pharmaceuticals.
READ MORE
Equipment

Introduction to the equipment and facilities of SPERA PHARMA that form our world class technology.
READ MORE

SPERA PHARMA is a pharmaceutical CMC R&D contract company spun out from the CMC Research Division of Takeda Pharmaceutical Co., Ltd. in July 2017.

Chemistry, Manufacturing and Controls (CMC) research experts, who were already responsible for delivering numerous new drugs to high global acclaim, is responsible for the entire CMC process, from R&D through application; it provides services that meet the needs of customers.
With "all" of our technologies, experiences and passion gathered globally, we will create your valuable candidate compounds into "1 tablet" of a pharmaceutical product.
Experts with extensive experience in process chemistry, formulation R&D, and analytical testing related to CMC research are available as a research team who work flexibly together to develop each process from the early development stage to drug application, providing high level services and solutions that meet your needs.